Exascale Labs Holdings Inc. XLAB
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -71.26% | -134.85% | 50.00% | ||
| Total Depreciation and Amortization | 0.00% | 0.00% | 50.00% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -50.04% | 62.46% | -44.48% | ||
| Change in Net Operating Assets | 854.03% | 1,743.66% | -294.58% | ||
| Cash from Operations | 23.60% | 347.93% | -1,740.63% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -102.54% | -100.00% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -101.18% | -74.06% | -1,778.44% | ||